Norovirus infection rates are extremely high this year, raising the question: Why can’t a vaccine protect us from the stomach ...
Moderna said on Friday that the U.S. FDA paused a late-stage trial of its experimental norovirus vaccine after a case of a ...
Norovirus is highly infectious and causing a lot of illness this winter. Several vaccine candidates are making their way through clinical trials.
Scientists are currently working on clinical trials on a norovirus vaccine, and are testing half a dozen potential solutions.
Moderna’s norovirus vaccine trial placed on FDA hold over reported case of Guillain-Barré syndrome
A trial of Moderna’s norovirus vaccine in the U.S. has been put on hold by the FDA over a reported case of neurological ...
Vaccines are available for the flu ... It also can be dangerous for the elderly and those who are inmunocompromised.
Experts say this is the worst flu season in the U.S. in more than a decade and cases are still trending up. Flu infections ...
EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake ...
(Reuters) -Moderna said on Friday that the U.S. FDA paused a late-stage trial of its experimental norovirus vaccine after a case of a rare neurological side effect was reported. The trial of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback